Houston Methodist enhances myelodysplastic syndrome treatment, researchHouston, TX - 11/5/2013
Clinicians and researchers at Houston Methodist recently received a $2 million donation to help the fight against an incurable form of blood cancer.
Dottie and Jimmy C. Adair donated the money in support of myelodysplastic syndrome (MDS) treatment and research at Houston Methodist Cancer Center. Jimmy Adair passed away in early 2013. The gift establishes a distinguished chair in hematology as well as a fund to further research, education and clinical activities focused on MDS. Dr. Lawrence Rice, a hematologist at Houston Methodist Hospital, leads this program.
Myelodysplastic syndromes are conditions in which bone marrow is unable to produce a certain class of blood cells called myeloid. About 12,000 Americans develop different types of myelodysplastic syndrome each year, which can turn into acute myeloid leukemia. While not as widely discussed, MDS received attention when ABC Good Morning America anchor Robin Roberts publicly discussed her own battle with the disease.
Depending on the type of MDS, treatment options may include chemotherapy (same drugs used to treat leukemia); drugs that affect the immune system; growth factors that encourage bone marrow to make more blood cells; blood transfusions; antibiotics; or stem cell transplants.